Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9861922 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL28418904 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL5385696 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL8736617 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL2555276 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL10494941 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL2555573 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL3272020 | 1.00 | LCK (0.50) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL8735257 | 0.98 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL5375201 | 0.98 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3601497-B1 | COMPOSITION, METHOD AND USE | INNOSPEC LTD (GB) | 2024-05-15 | — | — | EP | disclosed |
| EP-3601490-B1 | METHOD AND USE TO PREVENT DEPOSITS IN ENGINE | INNOSPEC LTD (GB) | 2023-09-27 | — | — | EP | disclosed |
| EP-3601212-B1 | COMPOSITION, METHOD AND USE | INNOSPEC LTD (GB) | 2023-09-06 | — | — | EP | disclosed |
| US-11186791-B2 | Composition, method and use | INNOSPEC LIMITED (GB) | 2021-11-30 | — | — | US | disclosed |
| US-11174442-B2 | Fuel compositions, methods and uses relating to quaternary ammonium salt additives for fuel used in spark ignition engines | INNOSPEC LIMITED (GB) | 2021-11-16 | — | — | US | disclosed |
| US-11015137-B2 | Composition, method and use | INNOSPEC LIMITED (GB) | 2021-05-25 | — | — | US | disclosed |
| US-20200377810-A1 | METHOD AND USE TO PREVENT DEPOSITS IN ENGINE | INNOSPEC LIMITED (GB) | 2020-12-03 | — | — | US | disclosed |
| US-20200354642-A1 | Fuel Composition Comprising Detergent and Quaternary Ammonium Salt Additive | INNOSPEC LIMITED (GB) | 2020-11-12 | — | — | US | disclosed |
| US-20200157445-A1 | COMPOSITION, METHOD AND USE | INNOSPEC LIMITED (GB) | 2020-05-21 | — | — | US | disclosed |
| US-20200040270-A1 | COMPOSITION, METHOD AND USE | INNOSPEC LIMITED (GB) | 2020-02-06 | — | — | US | disclosed |
| US-4663063-A | OIL AND FUEL ADDITIVES | THE LUBRIZOL CORPORATION (US) | 1987-05-05 | — | — | US | disclosed |
| US-4659338-A | ASHLESS DISPERSANT AND ALKALI OR ALKALINE EARTH METAL COMPOUND | THE LUBRIZOL CORPORATION (US) | 1987-04-21 | — | — | US | disclosed |
| WO-1987001126-A1 | FUEL PRODUCTS | THE LUBRIZOL CORPORATION (US) | 1987-02-26 | — | — | WO | disclosed |
| EP-0203969-A1 | ALKYL PHENOL AND AMINO COMPOUND COMPOSITIONS AND TWO-CYCLE ENGINE OILS AND FUELS CONTAINING SAME. | LUBRIZOL CORP (US) | 1986-12-10 | — | — | EP | disclosed |
| WO-1986003220-A1 | ALKYL PHENOL AND AMINO COMPOUND COMPOSITIONS AND TWO-CYCLE ENGINE OILS AND FUELS CONTAINING SAME | THE LUBRIZOL CORPORATION (US) | 1986-06-05 | — | — | WO | disclosed |
| EP-0148844-A1 | ALKYL PHENOL AND AMINO PHENOL COMPOSITIONS AND TWO-CYCLE ENGINE OILS AND FUELS CONTAINING SAME. | LUBRIZOL CORP (US) | 1985-07-24 | — | — | EP | disclosed |
| WO-1984003901-A1 | ALKYL PHENOL AND AMINO PHENOL COMPOSITIONS AND TWO-CYCLE ENGINE OILS AND FUELS CONTAINING SAME | LUBRIZOL CORP (US) | 1984-10-11 | — | — | WO | disclosed |
| EP-0062820-A2 | Polyamide film and process for the manufacture thereof | BAYER AG (DE) | 1982-10-20 | — | — | EP | disclosed |
| US-4200545-A | Amino phenol-detergent/dispersant combinations and fuels and lubricants containing same | THE LUBRIZOL CORPORATION (US) | 1980-04-29 | — | — | US | disclosed |
| US-4100082-A | Lubricants containing amino phenol-detergent/dispersant combinations | THE LUBRIZOL CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040270-A1 | COMPOSITION, METHOD AND USE | NR1H3, NR1H2, NR1I2 | LCK 1083/4885PPARD 1981/4885ZDHHC20 509/4885 |
| US-11015137-B2 | Composition, method and use | NR1H3, NR1H2, NR1I2 | LCK 1083/4885PPARD 1981/4885ZDHHC20 509/4885 |
| US-11186791-B2 | Composition, method and use | C5, H1-0, C9 | LCK 2505/4885PPARD 3780/4885ZDHHC20 2039/4885 |
| US-20200157445-A1 | COMPOSITION, METHOD AND USE | C5, H1-0, C9 | LCK 2505/4885PPARD 3780/4885ZDHHC20 2039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.